Mutation A713T in the amyloid precursor protein (APP) has been linked to cases of Alzheimer's disease (AD), cerebral amyloid angiopathy (CAA) and cerebrovascular disease. Despite its rarity, it has been observed in several families from the same geographical area, in the Calabria region in Southern Italy. Genotyping of 720,000 genome-wide SNPs with the HumanOmniExpress BeadChip was performed for six patients that were representative of apparently unrelated Calabrian families, as well as a Belgian subject of Italian descent (all with the same A713T mutation and disease). Their genomic structure and genetic relationships were analyzed. Demographic reconstruction and coalescent theory were applied to estimate the time of the most recent common ancestor (tMRCA) among patients. Results show that all A713T carriers fell into the genetic variability of Southern Italy and were not more closely related to each other than to any other healthy Calabrian individual. However, five out of seven patients shared a 1.7 Mbp-long DNA segment centered on the A713T mutation, making it possible to estimate a tMRCA for its common origin in the Calabrian region dating back over 1000 years. The analysis of affected individuals with methodologies based on human population genomics thus provides informative insights in support of clinical observations and biomedical research.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773445 | PMC |
| http://dx.doi.org/10.3390/biomedicines10010020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Amyloid Precursor Protein A713T Mutation in Calabrian Patients with Alzheimer's Disease: A Population Genomics Approach to Estimate Inheritance from a Common Ancestor.
Biomedicines
December 2021
Regional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Mutation A713T in the amyloid precursor protein (APP) has been linked to cases of Alzheimer's disease (AD), cerebral amyloid angiopathy (CAA) and cerebrovascular disease. Despite its rarity, it has been observed in several families from the same geographical area, in the Calabria region in Southern Italy. Genotyping of 720,000 genome-wide SNPs with the HumanOmniExpress BeadChip was performed for six patients that were representative of apparently unrelated Calabrian families, as well as a Belgian subject of Italian descent (all with the same A713T mutation and disease).
View Article and Find Full Text PDFGene Variants in Eight Chinese Patients With a Wide Range of Phenotypes.
Front Pediatr
December 2020
Department of Pediatric, Peking University First Hospital, Beijing, China.
The gene encodes the voltage-dependent P/Q-type calcium channel subunit alpha-1A, which is widely expressed throughout the CNS. The biological roles of the P/Q channel are diverse and the phenotypic spectrum caused by mutations is wide. The aim of this study is to demonstrate its phenotypic diversity and analyze the genotype-phenotype correlations in a cohort of Chinese patients.
View Article and Find Full Text PDFBoth gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome.
Epilepsia
September 2019
Sainte-Justine University Hospital Center, University of Montréal, Montréal, Canada.
Objective: Developmental epileptic encephalopathies (DEEs) are genetically heterogeneous severe childhood-onset epilepsies with developmental delay or cognitive deficits. In this study, we explored the pathogenic mechanisms of DEE-associated de novo mutations in the CACNA1A gene.
Methods: We studied the functional impact of four de novo DEE-associated CACNA1A mutations, including the previously described p.
Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease.
Neurobiol Aging
March 2016
Schools of Life Sciences and Medicine, Human Genetics, University of Nottingham, Nottingham, UK. Electronic address:
Early-onset Alzheimer's disease (EOAD) can be familial (FAD) or sporadic EOAD (sEOAD); both have a disease onset ≤65 years of age. A total of 451 sEOAD samples were screened for known causative mutations in exons 16 and 17 of the amyloid precursor protein (APP) gene. Four samples were shown to be heterozygous for 1 of 3 known causative mutations: p.
View Article and Find Full Text PDFHomozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.
Neurology
June 2015
From the Regional Neurogenetic Centre (M.E.C., L.B., G.P., N.S., M.G.M., S.A.M.C., R.C., M.G., M.A., F.F., A. Clodomiro, M.M., F.V., C.C., G.T., R.D.L., R.G.M., A.C.B.), ASP Catanzaro, Lamezia Terme; Department of Cell Biology and Neurosciences (P.P., A. Confaloni), National Institute of Health, Rome; and DINOGMI (P.M.), Università degli studi di Genova, Italy.
Objective: To report, for the first time, a large autosomal dominant Alzheimer disease (AD) family in which the APP A713T mutation is present in the homozygous and heterozygous state. To date, the mutation has been reported as dominant, and in the heterozygous state associated with familial AD and cerebrovascular lesions.
Methods: The family described here has been genealogically reconstructed over 6 generations dating back to the 19th century.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!